Itai Doron

Itai Doron

Auto-generated profile, based on publicly available information

Itai Doron

Gastroenterology and Hepatology Divison, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2018 in Science
Verified
Journal Article
Closed access
PDF file
ILIrina Leonardi
Irina Leonardi
XLXin Li
Xin Li
ASAlexa Semon
Alexa Semon
DLDalin Li
Dalin Li
IDItai Doron
Itai Doron
IIIliyan D. Iliev
Iliyan D. Iliev
Phagocytes patrol intestinal fungi: Maintaining a healthy balance of gut bacteria can promote good health. Leonardi et al. show that fungi can also interact with gut immune cells to maintain intestinal well-being. CX3CR1 + mononuclear phagocytes (MNPs) patrol the intestine and promote antifungal immunity. Genetic deletion of CX3CR1 in MNPs caused colitis-like symptoms in mice. CX3CR1 polymorphisms were detected in Crohn's disease patients that were unable to produce antibodies against multiple fungal species. Thus, commensal fungi may be as important as bacteria in maintaining gut health, and antifungal therapy could hold promise for treating intestinal inflammation. Science , this issue p. 232

3 October 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
MUMathieu Uzzan
Mathieu Uzzan
MTMinami Tokuyama
Minami Tokuyama
ARAdam K. Rosenstein
Adam K. Rosenstein
CTCostin Tomescu
Costin Tomescu
ISIvo SahBandar
Ivo SahBandar
SMSaurabh Mehandru
Saurabh Mehandru
Anti-α4β7 integrin therapy results in attrition of lymphoid aggregates within the gastrointestinal tract of HIV-1–infected individuals with IBD.